Results 191 to 200 of about 52,753 (266)

Efavirenz Interacts with Hormones Involved in Appetite and Satiety, Affecting Body Weight in Mice. [PDF]

Int J Mol Sci
Rojas-Osornio SA, Manuel-Apolinar L, Crespo-Ramírez M, Paredes-Cervantes V, Mata-Marín A, Molina-López J, Pérez de la Mora M, Borroto-Escuela D, Martínez-Lara R, Tesoro-Cruz E.   +9 more
europepmc   +1 more source

Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting

Artificial Cells Nanomedicine and Biotechnology, 2018
A. Belgamwar, Shagufta Khan, P. Yeole
semanticscholar   +1 more source

Lipid nanocapsule-chitosan and iota-carrageenan hydrogel composite for sustained hydrophobic drug delivery. [PDF]

Sci Rep
Mukubwa GK, Safari JB, Tetana ZN, Jones CN, Walker RB, Krause RWM.   +5 more
europepmc   +1 more source

Case Report: Efavirenz as a cause of ataxia in children

, 2015
Mpk Hauptfleish, DP Moore, JL Rodda
openalex   +1 more source

No Evidence for Induction of ABC Transporters in Peripheral Blood Mononuclear Cells in Humans after 14 Days of Efavirenz Treatment

, 2010
Jürgen Burhenne, Anne-Kathrin Matthée, Ivana Pasáková, Claudia Röder, T. Heinrich, Walter E. Haefeli, Gerd Mikus, Johanna Weiß   +7 more
openalex   +2 more sources

Efficacy and safety of efavirenz in Niemann-Pick disease type C. [PDF]

Neurotherapeutics
Gascón-Bayarri J, Rico I, Sánchez-Castañeda C, Ledesma MD, Carnaval T, Bejr-Kasem H, Campdelacreu J, Ferrer A, Rodríguez-Bel L, Cos M, de Lama E, López de Munain A, Rouco I, Pérez-Sousa C, Cerdán M, Muelas N, Sevillano MD, Mir P, Villoria J, Videla S.   +19 more
europepmc   +1 more source

Análisis cinético de la descomposición térmica del Efavirenz y estudios de compatibilidad con excipientes seleccionados [PDF]

, 2008
Osnir de Sá Viana, Adriano Antunes de Souza Araújo, Rodrigo Almeida Simões, José Lamartine Soares‐Sobrinho, Charlene Regina Santos Matos, Severino Grangeiro Júnior, Cláudio Moreira de Lima, Pedró José Rolim Neto   +7 more
openalex  

Nanoparticles in HIV treatment for improved drug delivery, clinical translation, and future direction. [PDF]

Discov Nano
Terkimbi SD, Dangana RS, Mbina SA, Paul-Chima UO, Aja PM, Mujinya R.   +5 more
europepmc   +1 more source

FORMULATION AND DEVELOPMENT OF EFAVIRENZ TABLETS BY PAPER TECHNIQUE USING CO-SOLVENCY METHOD

, 2019
CH. DHANA SUBRAHMANYESWARI, Y. Prasanth, SAMEEDA RUBEEN   +2 more
openalex   +2 more sources

Population Pharmacokinetic-Pharmacogenetic (PopPK-PGx) Model of Efavirenz in HIV-1-Infected Patients. [PDF]

Cureus
Vucicevic K, Michalickova D, Obradovic B, Ranin J, Jevtovic D, Lukic R, Owen A, Dragovic G.   +7 more
europepmc   +1 more source